Trevi Therapeutics, Inc. (TRVI)
USD 4.15
(-7.78%)
USD 4.15
(-7.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 123 Thousand | 43 Thousand | 50 Thousand | 47 Thousand | 39 Thousand | 23 Thousand |
| Gross Profit | -123 Thousand | -43 Thousand | -50 Thousand | -47 Thousand | -39 Thousand | -23 Thousand |
| Operating Expenses | 33.92 Million | 29.9 Million | 32.47 Million | 32.48 Million | 26.64 Million | 18.4 Million |
| Selling, General and Administrative Expenses | 10.24 Million | 10.07 Million | 9.49 Million | 10.16 Million | 7.3 Million | 4.33 Million |
| Research and Development Expenses | 23.68 Million | 19.83 Million | 22.98 Million | 22.32 Million | 19.33 Million | 14.07 Million |
| Other Expenses | - | 719 Thousand | -375 Thousand | -287 Thousand | 577 Thousand | -2.24 Million |
| Cost and Expenses | 33.92 Million | 29.9 Million | 32.47 Million | 32.48 Million | 26.64 Million | 18.4 Million |
| Operating Income | -33.92 Million | -29.9 Million | -32.47 Million | -32.48 Million | -26.64 Million | -18.4 Million |
| Interest Expense | 391 Thousand | 780 Thousand | 1.2 Million | 456 Thousand | - | 174 Thousand |
| Income Tax Expense | -32 Thousand | -36 Thousand | -21 Thousand | -18 Thousand | -18 Thousand | -124 Thousand |
| Earnings before Tax | -29.09 Million | -29.18 Million | -33.96 Million | -32.77 Million | -26.06 Million | -20.66 Million |
| Net Income | -29.06 Million | -29.15 Million | -33.94 Million | -32.75 Million | -26.05 Million | -20.54 Million |
| Earnings Per Share Basic | -0.29 | -0.45 | -1.49 | -1.81 | -2.22 | -2.29 |
| Earnings Per Share Diluted | -0.29 | -0.45 | -1.49 | -1.81 | -2.22 | -2.29 |
| Weighted Average Shares Outstanding | 99.03 Million | 64.54 Million | 22.84 Million | 18.05 Million | 11.73 Million | 8.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 99.03 Million | 64.54 Million | 22.84 Million | 18.05 Million | 11.73 Million | 8.96 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -33.8 Million | -29.86 Million | -32.42 Million | -32.44 Million | -26.6 Million | -18.38 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 176 Thousand | - | - | - |
| Cost of Revenue | 38 Thousand | 35 Thousand | 35 Thousand | 123 Thousand | 35 Thousand | 34 Thousand |
| Gross Profit | -38 Thousand | -35 Thousand | 141 Thousand | -123 Thousand | -35 Thousand | -34 Thousand |
| Operating Expenses | 13.25 Million | 11.87 Million | 8.89 Million | 33.8 Million | 9.04 Million | 8.38 Million |
| Selling, General and Administrative Expenses | 3.23 Million | 3.06 Million | 2.38 Million | - | 2.72 Million | 2.54 Million |
| Research and Development Expenses | 10.02 Million | 8.8 Million | 6.51 Million | - | 6.32 Million | 5.84 Million |
| Other Expenses | -5000.00 | -1000.00 | -3000.00 | - | 154 Thousand | 153 Thousand |
| Cost and Expenses | 13.28 Million | 11.9 Million | 8.93 Million | 33.92 Million | 9.04 Million | 8.38 Million |
| Operating Income | -13.28 Million | -11.9 Million | -8.93 Million | -33.92 Million | -9.04 Million | -8.38 Million |
| Interest Expense | 1000.00 | 1000.00 | 4000.00 | 391 Thousand | -3000.00 | 151 Thousand |
| Income Tax Expense | -8000.00 | -8000.00 | 18 Thousand | -32 Thousand | -13 Thousand | -30 Thousand |
| Earnings before Tax | -12.36 Million | -10.91 Million | -7.8 Million | -29.09 Million | -7.71 Million | -7.17 Million |
| Net Income | -12.35 Million | -10.9 Million | -7.82 Million | -29.06 Million | -7.69 Million | -7.14 Million |
| Earnings Per Share Basic | -0.12 | -0.11 | -0.08 | - | -0.08 | -0.07 |
| Earnings Per Share Diluted | -0.12 | -0.11 | -0.08 | - | -0.08 | -0.07 |
| Weighted Average Shares Outstanding | 101.04 Million | 99.51 Million | 99.48 Million | 99.03 Million | 99.32 Million | 98.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 101.04 Million | 99.51 Million | 99.48 Million | 99.03 Million | 99.32 Million | 98.69 Million |
| Gross Margin | - | - | 0.80 | - | - | - |
| EBIT Margin | - | - | -50.56 | - | - | - |
| Profit Margin | - | - | -44.44 | - | - | - |
| EBITDA | -13.25 Million | -11.87 Million | -8.89 Million | - | -9.04 Million | -6.99 Million |
| Earnings Before Tax Margin | - | - | -50.76 | - | - | - |
CRWD
HTIBP
PURSHOTTAM
003520
2441
BHAC